WFSBP is a Non-Profit World Wide Organization.

Composed of 64 National Societies of Biological Psychiatry and individual members.

Representing professionals from over 70 countries.

Our community is diverse. Our educational resources are too.

Become a Member of a Global Community.

Ever since its creation in 1974, the aim of WFSBP has been to promote in all countries the attainment of the highest level of knowledge and understanding in the field of Biological Psychiatry.

WELCOME TO WFSBP

Founded in 1974 in Buenos Aires, Argentina, WFSBP is a non-profit, international organization composed of 62 national societies of biological psychiatry, representing over 4,000 professionals. As a world authority on biological psychiatry, WFSBP is also highly committed to pioneering and promoting the highest levels of education and dissemination within the field.

Do you want to be informed about the latest issue of the World Journal of Biological Psychiatry? We can help!

During the General Assembly on 6 June 2024, the Executive Committee for the term 2024 - 2025 has been elected.

Subscribe to our mailing list and get the latest information about the WFSBP Educational Activities.

Membership and Service

Ever since its creation in 1974, the aim of WFSBP has been to promote in all countries the attainment of the highest level of knowledge and understanding in the field of Biological Psychiatry. Along the years WFSBP has become the common point where the variety of opinions highly contributes to bringing light to central questions on Psychiatry. As a consequence, WFSBP today gathers thousands of psychiatry related professionals from 102 countries around the world, making it a very enthusiastic and productive organization.

E-learning Series for Psychiatrists

We are extremely pleased to present a state-of-the-art program on cognitive function in psychiatric disorders entitled: Advancing Cognition Understanding in MENtal illness (ACUMEN): An E-learning Series for Psychiatrists. This innovative program aims to address clinicians' questions on cognitive function in subjects at high risk for or suffering from bipolar disorder or schizophrenia.

By participating in this program, you will have the opportunity to listen to leading international experts, discuss and share clinical insights on these important and highly relevant clinical topics.